|

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

RECRUITINGSponsored by University of Oklahoma
Actively Recruiting
SponsorUniversity of Oklahoma
Started2026-05-02
Est. completion2028-05-30
Eligibility
Age18 Years – 100 Years
SexMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06960798

Summary

The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.

Eligibility

Age: 18 Years – 100 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Written informed consent signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses.
* At least 18 years-of-age at the time of signature of the informed consent form (ICF).
* Patients who self-identify as Native American.
* Patients with a pathologically proven diagnosis of PC (any stage).
* Availability of most recent archived tumor samples.

Exclusion Criteria:

* Patients not of Native American descent or identity.
* Patient does not have archival tissue available.

Conditions2

CancerProstate Cancer

Locations1 site

OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, 73117
Adanma Ayanambakkam, MD405-271-4022Adanma-Ayanambakkam@ouhsc.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.